HUMPHREY RACHEL
Insider CIK 1579781 · CTMX Chief Medical Officer · BDTX Chief Medical Officer · PYXS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-03-24 | 2026-03-25 | 45,867 | — | $0 | 45,867 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2025-04-21 | 2026-03-25 | 13,896 | $1.03 | $14.3K | 81,309 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2025-04-17 | 2026-03-25 | 200 | $0.97 | $194 | 95,205 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | S Sale | 2025-04-14 | 2026-03-25 | 1,400 | $0.97 | $1.4K | 95,405 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2025-03-31 | 2025-04-02 | 36,979 | $0.98 | $36.2K | 36,979 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2024-03-26 | 2024-03-28 | 38,741 | — | $0 | 96,805 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2023-03-24 | 2023-03-28 | 58,064 | — | $0 | 58,064 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2022-08-11 | 2022-08-15 | 236,220 | — | $0 | 236,220 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-02-17 | 2021-02-19 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2020-09-08 | 2020-09-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2020-09-08 | 2020-09-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2019-01-25 | 2019-01-29 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2018-03-02 | 2018-03-05 | 16,160 | — | $0 | 222,980 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2018-03-02 | 2018-03-05 | 16,160 | $30.00 | $484.8K | 30,234 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2018-03-02 | 2018-03-05 | 16,160 | $6.61 | $106.8K | 46,394 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2018-02-28 | 2018-03-02 | 23,840 | — | $0 | 239,140 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2018-02-28 | 2018-03-02 | 23,840 | $6.61 | $157.6K | 54,074 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2018-02-28 | 2018-03-02 | 23,840 | $30.00 | $715.2K | 30,234 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2017-12-15 | 2017-12-19 | 15,117 | — | $0 | 262,980 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2017-12-15 | 2017-12-19 | 15,117 | $6.61 | $99.9K | 30,234 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2017-01-25 | 2017-01-27 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2016-12-28 | 2016-12-29 | 15,117 | — | $0 | 278,097 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2016-12-28 | 2016-12-29 | 15,117 | $6.61 | $99.9K | 15,117 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2016-01-21 | 2016-01-25 | 65,000 | — | $0 | 65,000 | SEC↗ |